ArticleBMC public health2026
Survival and predictors of mortality among adults with type 2 diabetes at a teaching hospital in Ghana: a retrospective cohort study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMortality rates remain high among individuals with type 2 diabetes. The rising cases of Diabetes Mellitus (DM) have negatively impacted society’s development, health and have impoverished individuals. T2DM among other types has the highest prevalence among all populations. The rising prevalence of diabetes in Ghana has become a serious public health concern. It demands extensive research to identify factors that need public health action to improve survival and to reduce suffering and complications and to inform policy decisions towards finding effective treatment and management of the disease. This study aimed to estimate the median survival time and determine the key predictors of mortality among diabetes patients in the Tamale Teaching Hospital.
methodsThis study employed a retrospective cohort study design. A total of 458 participants were included, of which 18.38% had died, after extracting the medical records of all diabetes patients admitted between 2021 and 2024 from the Lightwave Health Information Management System (LHIMS). Descriptive statistics were carried out to summarise socio-demographic and clinical variables. Kaplan-Meier curve was used to examine the cumulative, median and treatment regimen survival probabilities among patients. The Schoenfeld residual test was performed to establish Cox proportional assumption test and variables that satisfy the assumptions were selected with p-values ≤ 0.25 from bivariate Cox regression analysis into Multivariable Cox model. Multivariable Cox model was fitted to examine the adjusted association between significant variables and mortality.
resultsThe overall survival was 93.05%, 81.5% and 73.7% for first, second and third years respectively. The median survival time was 1.52 years [(IQR = 0.87–2.09). The variables included in the adjusted Cox proportional hazard analysis were; education, age group, occupation, chronic kidney disease, stroke, treatment regimen, health insurance and BMI. In the adjusted Cox PH model, patients with basic education had higher risk of death (HR = 6.66, 95% CI: 2.55–17.37) from T2DM compared to those with no education. Self-employed participants had lower risk of death (HR = 0.41, 95% CI: 0.22–0.75). Oral and Insulin combination increased the risk of death (HR = 16.63, 95% CI = 2.28–121.35). Stroke elevated the risk of death (HR = 2.75, 95% CI: 1.41–5.36).
conclusionT2DM patients had a decreasing survival year-on-year, with a very short median survival time. The factors that predict mortality among T2DM patients are education, employment, treatment regimen and stroke. Hospitalised diabetics especially those with stroke should be given intensive care including oral anti-diabetic medications to ensure better survival outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.